New York, NY -- (SBWIRE) -- 01/28/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Mallinckrodt PLC (NYSE:MNK), Celldex Therapeutics, Inc.(NASDAQ:CLDX), 3D Systems Corporation (NYSE:DDD), Pharmacyclics, Inc.(NASDAQ:PCYC)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Mallinckrodt PLC (NYSE:MNK) opened its shares at the price of $57.00 for the day. Its closing price was $56.41 after losing -5.07% for the day. The company traded with the total volume of 1.52 million shares, while its average trading volume remained 643,879.00 shares. Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API), and diagnostic imaging agents worldwide.
Has MNK Found The Bottom and Ready To Move Up? Find Out Here
Celldex Therapeutics, Inc.(NASDAQ:CLDX) percentage change plunged -5.05% to close at $25.77 with the total traded volume of 2.26 million shares, and average volume of 2.12 million. The 52 week range of the stock remained $6.90 - $38.84, while its day lowest price was $25.01 and it hit its day highest price at $27.09. Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.
Has CLDX Found The Bottom And Ready To Gain Momentum? Find Out Here
3D Systems Corporation (NYSE:DDD) started its trading session with the price of $77.51 and closed at $75.90 by scoring -4.97%. DDD’s stocks traded with total volume of 9.42 million shares, while the average trading volume remained 5.24 million shares. The beta of DDD stands at 1.92. Day range of the stock was $72.70 -$77.90. 3D Systems Corporation, through its subsidiaries, develops, manufactures and markets 3D printers, print materials, on-demand custom parts services, and 3D authoring solutions for professionals and consumers.
Why Should Investors Buy DDD After the Recent Fall? Just Go Here and Find Out
Pharmacyclics, Inc.(NASDAQ:PCYC) ended its day with the loss of -4.89% and closed at the price of $128.59 after opening at $135.15. Stock traded during its last trading session with the total volume of 1.37 million shares, as compared to its average volume of 1.29 million shares. Pharmacyclics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of small-molecule drugs for the treatment of cancer and immune mediated diseases. Its principal products candidates in clinical development include ibrutinib.
Will PCYC Get Buyers Even After The Recent Rally? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)